(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.34%) $78.11
(0.23%) $2.21
(0.02%) $2 324.60
(0.13%) $27.58
(-0.07%) $987.70
(0.17%) $0.931
(0.46%) $10.95
(0.20%) $0.801
(0.00%) $91.45
5 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 0.00%
@ $29.19
Issued: 12 Feb 2024 @ 15:57
Return: 16.27%
Previous signal: Feb 12 - 09:41
Previous signal:
Return: -10.43 %
Live Chart Being Loaded With Signals
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease...
Stats | |
---|---|
Today's Volume | 71 792.00 |
Average Volume | 137 645 |
Market Cap | 436.23M |
EPS | $0 ( 2024-05-06 ) |
Next earnings date | ( $-1.030 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.144 (0.42%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-13 | Mcminn Rachel | Buy | 93 282 | Employee Stock Option (Right to buy) |
2024-03-13 | Cvijic Christine Mikail | Buy | 53 900 | Employee Stock Option (Right to buy) |
2024-03-13 | Cvijic Christine Mikail | Buy | 31 903 | Common Stock |
2024-03-13 | Cobb Stuart | Buy | 34 450 | Stock Option (Right to Buy) |
2024-03-13 | Cobb Stuart | Buy | 20 391 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 13 transactions |
Buy: 3 111 176 | Sell: 0 |
Volume Correlation
Neurogene Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Neurogene Inc. Correlation - Currency/Commodity
Neurogene Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-3.26M (0.00 %) |
EPS: | $-7.79 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-3.26M (0.00 %) |
EPS: | $-7.79 |
Financial Reports:
No articles found.
Neurogene Inc.
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators